Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

IMIQUIMOD 3.75% CREAM PUMP

imiquimod
$24.3913per GM

Strength

37.5 mg/g

Manufacturer

Oceanside Pharmaceuticals

NDC

68682027275

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Last Updated

7/23/2025

Active Ingredients

IMIQUIMOD

Approval Type

New Drug (NDA)

FDA Application

NDA022483

On Market Since

6/27/2018

Pharmacological Classes

Increased Cytokine Activity
Increased Cytokine Production
Interferon Inducers

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.0%

3Y

N/A

5Y

N/A

All

-37.4%

Generic Alternatives

2 alternatives • Same active ingredient

IMIQUIMOD 3.75% CREAM PUMP
Generic
00093313331•Teva Pharmaceuticals USA Inc.
$118.6295
+386% more
ZYCLARA 3.75% CREAM PUMP
Brand
99207027175•Bausch Health US LLC
$158.1732
+548% more

Related Drugs

Same classification

IMIQUIMOD 5% CREAM PACKET
Generic
45802036862•Padagis Israel Pharmaceuticals Ltd
$0.6644
per EA
IMIQUIMOD 5% CREAM PACKET
Generic
51672414506•Sun Pharmaceutical Industries Inc.
$0.6644
per EA
IMIQUIMOD 5% CREAM PACKET
Generic
68462053670•Glenmark Pharmaceuticals Inc., USA
$0.6644
per EA
IMIQUIMOD 5% CREAM PACKET
Generic
45802036853•Padagis Israel Pharmaceuticals Ltd
$11.8204
per EA
IMIQUIMOD 3.75% CREAM
Generic
51672417406•Sun Pharmaceutical Industries Inc.
$22.0395
per EA
IMIQUIMOD 3.75% CREAM PUMP
Generic
51672417409•Sun Pharmaceutical Industries Inc.
$118.6295
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy